Notch signaling specifies megakaryocyte development from hematopoietic stem cells |
| |
Authors: | Mercher Thomas Cornejo Melanie G Sears Christopher Kindler Thomas Moore Sandra A Maillard Ivan Pear Warren S Aster Jon C Gilliland D Gary |
| |
Affiliation: | Department of Medicine, Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 20115, USA. tmercher@rics.bwh.harvard.edu |
| |
Abstract: | ![]() In the hematopoietic system, Notch signaling specifies T cell lineage fate, in part through negative regulation of B cell and myeloid lineage development. However, we unexpectedly observed the development of megakaryocytes when using heterotypic cocultures of hematopoietic stem cells with OP9 cells expressing Delta-like1, but not with parental OP9 cells. This effect was abrogated by inhibition of Notch signaling either with gamma-secretase inhibitors or by expression of the dominant-negative Mastermind-like1. The importance of Notch signaling for megakaryopoietic development in vivo was confirmed by using mutant alleles that either activate or inhibit Notch signaling. These findings indicate that Notch is a positive regulator of megakaryopoiesis and plays a more complex role in cell-fate decisions among myeloid progenitors than previously appreciated. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|